Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Fancy who wrote (6019)	1/28/1999 10:56:00 AM
From: FNS	Read Replies (1) of 6136

Steve: >>I was concerned that something is wrong.<< Definitely, read some info where AGPH might be having future problems with competition and lack of new drugs in pipeline and that management went for the deal. Unfortunately, I think AGPH was underbought and had management waited till post earnings, the stock may have gone to 60 and higher on technical breakout with shakeout completed....but that's a big assumption on earnings part and not knowing what kind of forward looking statement would be issued. So...ciao! ciao!...out at 59 with 20 point st gain...will continue via other drug stocks and techies, but 'cautiouly' due to overall market! FNS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next